
ONWARD Medical Completes Two Additional Brain-Computer Interface Implants Paired with Spinal Cord Stimulation Technology to Restore Thought-Driven Movement
EINDHOVEN, the Netherlands, Jan. 22, 2026 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the neurotechnology company pioneering spinal cord stimulation therapies to restore movement, function, and independence, announces that two additional individuals living with spinal cord injuries (SCI) have received the Company's investigational ARC-BCI® Therapy. These groundbreaking procedures bring the total number of human implants to seven, extending the Company's leadership in the development of brain-computer interface (BCI) platforms to restore thought-driven movement for people living with paralysis.


















